ARG References - STD information from CDC

Antibiotic Resistant Gonorrhea

Antibiotic-Resistant Gonorrhea (ARG)
Resources and References

Resources

STD Surveillance Reports

Annual Reports (all years)

Fact Sheets and General Information

Gonorrhea - CDC Fact Sheet. (en Español)
Basic Information about Antibiotic-Resistant Gonorrhea (ARG)
Quinolones and the Clinical Laboratory - information from CDC.
B88 document- Neisseria gonorrhoeae reference strains for antimicrobial susceptibility testing
Antimicrobial Resistance (all diseases)
Public Health Action Plan to Combat Antimicrobial Resistance- United States

International

References

MMWRs

Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections - MMWR April 13, 2007
Notice to Readers: Discontinuation of Spectinomycin - MMWR April 7, 2006
Increases in Fluoroquinolone-Resistant Neisseria gonorrhoeae Among Men Who Have Sex with Men --- United States, 2003, and Revised Recommendations for Gonorrhea Treatment, 2004 - MMWR. 30 April 2004
Increases in Fluoroquinolone-Resistant Neisseria gonorrhoeae --- Hawaii and California, 2001 22 November 2002 (Print Version )
Alternatives to Spectinomycin for the Treatment of Neisseria Gonorrhoeae 8 June 2001
Fluoroquinolone-Resistance in Neisseria gonorrhoeae, Hawaii, 1999, and Decreased Susceptibility to Azithromycin in N. gonorrhoeae, Missouri, 1999 22 September 2000 (Print Version )
Fluoroquinolone-Resistant Neisseria gonorrhoeae -- San Diego, California, 1997. 29 May 1998
Gonorrhea Among Men Who Have Sex with Men -- Selected Sexually Transmitted Diseases Clinics, 1993-1996. 26 September 1997 (Print Version)
Fluoroquinolone Resistance in Neisseria gonorrhoeae- Colorado and Washington, 1995. 20 October 1995 (Print Version)
Sentinel Surveillance for Antimicrobial Resistance in Neisseria gonorrhoeae- United States, 1988-1991. 13 August 1993 (Print Version)
Antibiotic-Resistant Strains of Neisseria gonorrhoeae: Policy Guidelines for Detection, Management, and Control. (Sept 11, 1987) Vol 36/ No.5S: 1-18.
Sentinel Surveillance for Antimicrobial Resistance in Clinical Isolates of Neisseria gonorrhoeae. 11 September 1987

GISP Publications and Abstracts

Wang SA, Harvey AB, Conner SM, Zaidi AA, Knapp JS, Whittington WL, del Rio C, Judson FN, Holmes KK. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Annals of Internal Medicine. 2007 Jul 17;147(2):81-8.
Siedner MJ, Pandori M, Castro L, Barry P, Whittington WL, Liska S, Klausner JD. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. Journal of Clinical Microbiology. 2007 Apr;45(4):1250-4.
Bauer HM, Hannah P, Moore D, Wolfe J, Knapp J, Trees D, Wang S, Bolan G. Molecular epidemiology of quinolone-resistant Neisseria gonoeehoeae in California, 2000-2002. [Abstract 283] 15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research, Ottawa, Canada, July 27-30, 2003.
Conner SM, Wang SA, Weinstock HS. Ciprofloxacin resistant gonorrhea within the continental United States, 1991-2000 [Abstract]. 2002 National STD Prevention Conference, San Diego, CA. March 4-7, 2002.
Fox KK, del Rio C, Holmes KK, Hook EW, Judson FN, Knapp JS, Procop GW, Wang SA, Whittington WL, Levine WC. Gonorrhea in the HIV Era: A Reversal in Trends Among Men Who Have Sex With Men. American Journal of Public Health. 2001;91:959-964.
Fox KK, Knapp JS, Homes KK, Hook EW, Judson FN, Thompson SE, Washington JA, Whittington WL. Antimicrobial Resistance in Neisseria gonorrhoeae in the United States, 1988-1994: The Emergence of Decreased Susceptibility to the Fluoroquinolones. Journal of Infectious Disease. 1997;175:1396-1403.
Iverson CJ, Wang SA, Ohye R, Lee V, Domen H, Neal S, Trees D, Whiticar P, Effler P. Emergence of a possible endemic focus of ciprofloxacin-resistant Neisseria gonorrhoeae in Hawaii. [Abstract] Second International Conference on Emerging Infectious Diseases, Atlanta, GA. July 16-19, 2000.
Johnson SR, Sandul AL, Parekh M, Wang SA, Knapp JS, Trees DL. Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae. International Journal of Antimicrobial Agents. 2003;21:414-419.
Katz AR, Lee MV, Ohye RG, Whiticar PM, Effler PV. Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002. The Lancet. 2003;362(9382):495.
>Knapp JS, Fox KK, Trees DL, Whittington WL. Fluoroquinolone Resistance in Neisseria gonorrhoeae. Emerging Infectious Diseases. 1997;3:33-39.
Mark KE, Bauer HM, Gunn RA, Wang SA, Knapp JS, Moore DS, Weismuller P, Klausner JD, De Augustine N, Bolan G, and the California Resistance Working Group. Increase in fluoroquinolone-resistant Neisseria gonorrhoea- California, 2001 [Abstract 21]. 40th Annual Meeting of the Infectious Diseases Society of America, Chicago, Illinois, October 24-27, 2002.
McLean CA, Wang SA, Hoff G, Dennis L, Neal S, Knapp J, Markowitz L, Levine WC. Emergence of Neisseria gonorrhoeae with decreased susceptibility to azithromycin associated with commercial sex in Kansas City, Missouri, 1999. [Abstract 543] 38th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA. September 7-10, 2000.
McLean CA, Wang SA, Hoff GL, Dennis LY, Trees DL, Knapp JS, Markowitz LE, Levine WC. The emergence of Neisseria gonorrhoeae with decreased susceptibility to azithromycin in Kansas City, Missouri, 1999-2000. Sexually Transmitted Diseases 2004;31:73-78.
Newman LM, Wang, SA, Ohye RG, Lee MV, Weinstock, HS. The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001. Clinical Infectious Diseases 2004;38:649-654.
Newman LM, Wang SA, Weinstock HS. Emergence of ciprofloxacin-resistant Neisseria gonorrhoea prevalence and risk factors for infection- United States, 1998-2000 [Abstract 651]. 40th Annual Meeting of the Infectious Diseases Society of America, Chicago, Illinois, October 24-27, 2002.
Roy K, Wang S, Meltzer M. Identifying the optimal diagnostic and treatment strategy for gonorrhea in a time of increasing ciprofloxacin-resistance [Abstract]. 2002 National Foundation for Infectious Diseases Conference on Antimicrobial Resistance, Bethesda, Maryland, June 27-29, 2002.
Schwarcz SK, Zenilman JM, Schnell D, Knapp JS, Hook EW, Thompson S, Judson FN, Holmes KK. National Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae. JAMA. 1990;264:1413-1417.
Wang SA. The continuing saga of gonococcal resistance : current epidemiology and challenges. 2002 National Foundation for Infectious Diseases Conference on Antimicrobial Resistance, Bethesda, Maryland, June 29, 2002.
Wang SA, Harvey AB, Conner SM, Weinstock HS. Gonococcal susceptibility and epidemiological trends: data from the Gonococcal Isolate Surveillance Project, United States, 2002. [Abstract 284] 15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research, Ottawa, Canada, July 27-30, 2003.
Wang SA, Harvey AB, Conner SM, Weinstock HS, and the Gonococcal Isolate Surveillance Project Investigators. Trends in gonococcal susceptibility and epidemiology in the United States for 2002 identified through the Gonococcal Isolate Surveillance Project. [Abstract 924]. 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, October 9-10, 2003.
Wang SA, Harvey AB, Weinstock HS. Antimicrobial susceptibilities of Neisseria gonorrhoeae in the United States [Abstract 401]. Thirteenth International Pathogenic Neisseria Conference , Olso, Norway, September 1-6, 2002.
Wang SA, Lee MV, Iverson CJ, O'Connor N, Ohye RG, Hale JA, Knapp JS, Effler PV, Weinstock HS. Multi-drug resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime, Hawaii 2001. [Abstract] International Conference on Emerging Infectious Diseases, Atlanta, Georgia. March 25, 2002.
Wang SA, Lee MVC, Norman O'Connor N, Iverson CJ, Ohye RG, Whiticar PM, Hale JA, Trees DL, Knapp JS, Effler PV, Weinstock HS. Multi-drug resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime, Hawaii, 2001. Clinical Infectious Diseases 2003;37:849-52
Wang SA, Lee MVC, O'Connor N, Iverson CJ, Ohye RG, Whiticar PM, Hale JA, Trees DL, Knapp JS, Effler PV, and Weinstock HS. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime -- Hawaii, 2001. Clinical Infectious Diseases 2003;37:849-52

Other Relevant Publications and Abstracts

WHO. Surveillance of Antibiotic Resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2007-2008. Communicable Diseases Intelligence, 2010; 34(1): 1-7.
The Australian Gonococcal Surveillance Programme. Annual Report of the Australian Gonococcal Surveillance Programme, 2008. Communicable Diseases Intelligence. 2009;33(3):268-274.
Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug and extensively drug-resistant Neisseria gonorrhoeae. Expert Review of Anti-Infective Therapy. 2009;7(7):821-834.
Lo JY, Ho KM, Leung AO, Tiu FS, Tsang GK, Lo AC, et al. Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. . Antimicrobial Agents and Chemotherapy. 2008;52(10):3564-3567.
Yokoi S, Deguchi T, Ozawa Y, Yasuda M, Ito S, Kubota Y, et al. Threat to cefixime treatment for gonorrhea. Emerging Infectious Diseases. 2007;13(8):1275-1277.
Ito M, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrobial Agents and Chemotherapy. 2004;48(8):3185-3187.
Akasaka S, Muratani T, Kobayashi T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T. Gonococcal urethritis and cervicitis caused by CZRNG (cefozopran-resistant Neisseria gonorrhoeae)- clinical failure cases treated with expanded spectrum cephems, fluoroquinolones and minocycline [Abstract]. Thirteenth International Pathogenic Neisseria Conference, Norwegian Institute of Public Health, Olso, Norway. September 1-6, 2002.
Etkind P, Ratelle S, and George H. International travel and sexually transmitted disease. Emerging Infectious Diseases. [Letter] 2003;9(12):654-1656.
Muratani T, Kobayashi T, Yamada Y, Akasaka S, Inatomi H, Takahashi K, Matsumoto T. Prevalence of super multi-drug resistant Neisseria gonorrhoeae CZRNG (cefozopran-resistant N. gonorrhoeae) in Japan. Thirteenth International Pathogenic Neisseria Conference, Norwegian Institute of Public Health, Olso, Norway. September 1-6, 2002.